or Try an Advanced Search...

    Eye Care Products Stocks List

    Symbol Grade Name % Change
    NVS B Novartis AG -1.52
    ABBV C AbbVie Inc. -4.67
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major
    Related Stock Lists: Pharmaceutical Active Pharmaceutical Ingredients Adalimumab Advanced Prostate Cancer Anemia Animal Health Antibiotics Atopic Dermatitis Autoimmune Disease Biotechnology Blood Cancers Blood Test Chronic Idiopathic Constipation Combination Drugs Constipation Contact Lens Contact Lenses Crohn's Disease Depressive Disorder Diagnostic Products

    Related ETFs - A few ETFs which own one or more of the above listed Eye Care Products stocks.

    Symbol Grade Name Weight
    EWL D iShares MSCI Switzerland Capped Index Fund 16.96
    FLSW D Franklin FTSE Switzerland ETF 16.16
    MEDX F Horizon Kinetics Medical ETF 13.11
    PPH B Market Vectors Pharmaceutical ETF 10.58
    MEDI C Harbor Health Care ETF 9.87
    View all Eye Care Products ETFs...
    Compare ETFs
    Compare EWL to PPH Compare FLSW to MEDX Compare MEDX to PPH

        Eye Care Products Stocks Recent News

        Date Stock Title
        Apr 26 ABBV Tech Stocks Rebound As Magnificent 7 Roar On Strong Earnings, Energy Giants Tumble: What's Driving Markets Friday?
        Apr 26 NVS Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
        Apr 26 ABBV Ex-Humira Growth Platform Drives AbbVie's Q1 Performance, Drugmaker Lifts Annual Profit Outlook
        Apr 26 ABBV AbbVie Inc (ABBV) Q1 2024 Earnings: Adjusted EPS Tops Estimates Despite Revenue Challenges
        Apr 26 ABBV AbbVie in charts: Q1 Skyrizi, Rinvoq sales jump, while revenue from Humira continues to fall
        Apr 26 ABBV AbbVie Beats First-Quarter Views As Skyrizi Looks To Take Humira's Title
        Apr 26 ABBV AbbVie lifts profit forecast after Skyrizi sales beat expectations
        Apr 26 ABBV AbbVie Non-GAAP EPS of $2.31 beats by $0.05, revenue of $12.31B beats by $370M
        Apr 26 ABBV AbbVie raises annual profit forecast on strong Skyrizi sales
        Apr 26 ABBV AbbVie Reports First-Quarter 2024 Financial Results
        Apr 26 ABBV PCE reading, Microsoft, Alphabet jump on earnings: Yahoo Finance
        Apr 25 ABBV Cigna to offer Humira rivals with $0 copay at specialty pharmacy
        Apr 25 ABBV AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
        Apr 25 ABBV AbbVie reports positive results from Rinvoq versus Dupixent study
        Apr 25 ABBV AbbVie Q1 Preview: Skyrizi and Rinvoq’s launches could help Q1
        Apr 25 ABBV UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
        Apr 25 ABBV Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
        Apr 25 NVS Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
        Apr 25 ABBV New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
        Apr 24 ABBV AbbVie breaks six day winning cycle, trades in the red
        Related Industries: Drug Manufacturers - Major
        Related Stock Lists: Pharmaceutical Active Pharmaceutical Ingredients Adalimumab Advanced Prostate Cancer Anemia Animal Health Antibiotics Atopic Dermatitis Autoimmune Disease Biotechnology Blood Cancers Blood Test Chronic Idiopathic Constipation Combination Drugs Constipation Contact Lens Contact Lenses Crohn's Disease Depressive Disorder Diagnostic Products
        Eye Care Products

        Eye care products are products designed to help maintain healthy eyes and vision. These products can include eye drops, contact lenses, glasses, sunglasses, and other vision aids. They can also include products designed to help protect the eyes from environmental hazards, such as UV radiation, dust, and wind.

        Browse All Tags